SCPS

Scopus BioPharma (SCPS)

Scopus BioPharma Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:SCPS

1 2 3 4 5 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2023/11/02	22:15	GlobeNewswire Inc.	Scopus BioPharma’s Subsidiary — Duet BioTherapeutics — to Present at the 38th Annual Meeting of the Society for Immunotherapy of Cancer	NASDAQ:SCPS	Scopus BioPharma Inc
2023/06/29	06:16	Edgar (US Regulatory)	Proxy Soliciting Materials (revised) (prer14a)	NASDAQ:SCPS	Scopus BioPharma Inc
2023/05/13	06:16	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:SCPS	Scopus BioPharma Inc
2023/04/29	06:05	Edgar (US Regulatory)	Amended Annual Report (10-k/a)	NASDAQ:SCPS	Scopus BioPharma Inc
2023/04/15	06:01	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:SCPS	Scopus BioPharma Inc
2022/12/16	20:06	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SCPS	Scopus BioPharma Inc
2022/12/03	07:17	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	NASDAQ:SCPS	Scopus BioPharma Inc
2022/11/22	07:17	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:SCPS	Scopus BioPharma Inc
2022/11/16	07:16	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	NASDAQ:SCPS	Scopus BioPharma Inc
2022/11/10	23:15	GlobeNewswire Inc.	Scopus BioPharma’s Subsidiary — Duet BioTherapeutics — Announces Key Scientific Data to be Presented at the 37th Annual Meeting and Exposition of the Society for Immunotherapy of Cancer	NASDAQ:SCPS	Scopus BioPharma Inc
2022/10/18	22:25	GlobeNewswire Inc.	Scopus Biopharma Completes Recapitalization Designed To Enhance Shareholder Value	NASDAQ:SCPS	Scopus BioPharma Inc
2022/09/03	06:16	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SCPS	Scopus BioPharma Inc
2022/05/28	06:46	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SCPS	Scopus BioPharma Inc
2022/05/20	06:16	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:SCPS	Scopus BioPharma Inc
2022/05/14	06:17	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SCPS	Scopus BioPharma Inc
2022/05/05	21:30	GlobeNewswire Inc.	Scopus BioPharma Announces Biotechnology Industry Leader Rejoins Board of Directors	NASDAQ:SCPS	Scopus BioPharma Inc
2022/05/05	06:17	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SCPS	Scopus BioPharma Inc
2022/05/03	05:47	Edgar (US Regulatory)	Amended Annual Report (10-k/a)	NASDAQ:SCPS	Scopus BioPharma Inc
2022/04/30	06:38	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SCPS	Scopus BioPharma Inc
2022/04/16	05:18	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:SCPS	Scopus BioPharma Inc
2022/04/09	06:16	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SCPS	Scopus BioPharma Inc
2022/04/02	06:17	Edgar (US Regulatory)	Notification That Annual Report Will Be Submitted Late (nt 10-k)	NASDAQ:SCPS	Scopus BioPharma Inc
2022/03/25	06:17	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SCPS	Scopus BioPharma Inc
2022/03/23	19:31	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SCPS	Scopus BioPharma Inc
2022/03/23	09:30	GlobeNewswire Inc.	Scopus BioPharma’s Subsidiary — Duet BioTherapeutics — to Present at the 3rd Annual STING & TLR-Targeting Therapies Summit	NASDAQ:SCPS	Scopus BioPharma Inc
2022/03/05	07:17	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SCPS	Scopus BioPharma Inc
2022/02/19	07:17	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SCPS	Scopus BioPharma Inc
2022/01/21	07:17	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SCPS	Scopus BioPharma Inc
2022/01/20	22:35	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(2) (424b2)	NASDAQ:SCPS	Scopus BioPharma Inc
2022/01/19	20:07	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:SCPS	Scopus BioPharma Inc